Benzinga's Top Downgrades

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP ) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday. Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN ) from “overweight” to “neutral.”